4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0000950170-24-067953
Chief Financial Officer bought 25,006 shares at an average $1.40 ($35,007)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hunt Jonathan Robert Chief Financial Officer | 2024-05-31 | Purchase | +13,006 | $1.40 | $18,207 | 329,716 | D: show line 1 in the form |
| Hunt Jonathan Robert Chief Financial Officer | 2024-05-31 | Purchase | +12,000 | $1.40 | $16,800 | 341,716 | D: show line 2 in the form |
| Open-market purchases · 25,006 sh · avg $1.40 · $35,007 | |||||||
Loading xslF345X05/ownership.xml…